Kai kai Chang

Dr. Kai kai Chang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
HWHuan Wang
Huan Wang
QCQi Cheng
Qi Cheng
LBLingjie Bao
Lingjie Bao
MLMingqing Li
Mingqing Li
KCKai kai Chang
Kai kai Chang
XYXiaofang Yi
Xiaofang Yi
Chemoresistance remains the foremost challenge in cancer therapy. Targeting reactive oxygen species (ROS) manipulation is a promising strategy in cancer treatment since tumor cells present high levels of intracellular ROS, which makes them more vulnerable to further ROS elevation than normal cells. Nevertheless, dynamic redox evolution and adaptation of tumor cells are capable of counteracting therapy-induced oxidative stress, which leads to chemoresistance. Hence, exploring the cytoprotective mechanisms of tumor cells is urgently needed to overcome chemoresistance. Heme oxygenase-1 (HO-1), a rate-limiting enzyme of heme degradation, acts as a crucial antioxidant defense and cytoprotective molecule in response to cellular stress. Recently, emerging evidence indicated that ROS detoxification and oxidative stress tolerance owing to the antioxidant function of HO-1 contribute to chemoresistance in various cancers. Enhanced HO-1 expression or enzymatic activity was revealed to promote apoptosis resistance and activate protective autophagy, which also involved in the development of chemoresistance. Moreover, inhibition of HO-1 in multiple cancers was identified to reversing chemoresistance or improving chemosensitivity. Here, we summarize the most recent advances regarding the antioxidant, antiapoptotic, and pro-autophagy properties of HO-1 in mediating chemoresistance, highlighting HO-1 as a novel target for overcoming chemoresistance and improving the prognosis of cancer patients.

10 June 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
JRJingyao Ruan
Jingyao Ruan
QTQi Tian
Qi Tian
SLSiting Li
Siting Li
XZXiaoyu Zhou
Xiaoyu Zhou
QSQianzhi Sun
Qianzhi Sun
XYXiaofang Yi
Xiaofang Yi
Objectives: Interleukin 33 (IL-33) is a crucial inflammatory factor that functions as an alarm signal in endometriosis (EMs). Epithelial-mesenchymal transition (EMT), a process related to inflammatory signals, intracellular reactive oxygen species (ROS) production, and lipid peroxidation, have been proposed as potential mechanisms that contribute to the development and progression of EMs. IL-33 is highly upregulated in the ectopic milieu. Moreover, ectopic endometrial cells constitutively express interleukin-33 receptor ST2 (IL-33R). However, the role of IL-33/ST2 in the EMT of EMs remains largely unknown. In this study, we aimed to mechanistically determine the role of IL-33/ST2 in EMs-associated fibrosis. Materials and methods: We established a non-lethal oxidative stress model to explore the conditions that trigger IL-33 induction. We performed α-smooth muscle actin (α-SMA) protein detection, cell counting kit-8 (CCK-8) assays, and scratch assays to analyze the impact of IL-33 on primary endometrial stromal cells (ESCs) proliferation and invasion. Clinical samples from patients with or without EMs were subjected to immunohistochemical (IHC) and and immunofluorescence(IF) staining to assess the clinical relevance of IL-33 receptor ST2 and EMT-related proteins. Furthermore, we used the ectopic human endometrial epithelial cell line 12Z and normal human epithelial cell line EEC to evaluate the effects of IL-33 on Wnt/β-catenin signaling. The effect of IL-33 on EMT-associated fibrosis was validated in vivo by intraperitoneal injections of IL-33 and antiST2. Results: We observed that ectopic milieu, characterized by ROS, TGF-β1, and high level of estrogen, triggers the secretion of IL-33 from ectopic ESCs. Ectopic endometrial lesions exhibited higher level of fibrotic characteristics and ST2 expression than that in the normal endometrium. Exogenous recombinant human (rhIL-33) enhanced ESC migration and survival. Similarly, 12Z cells displayed a higher degree of EMT characteristics with elevated expression of CCN4 and Fra-1, downstream target genes of the WNT/β-catenin pathway, than that observed in EECs. Conversely, blocking IL-33 with neutralizing antibodies, knocking down ST2 or β-catenin with siRNA, and β-catenin dephosphorylation abolished its effects on EMT promotion. In vivo validation demonstrated that IL-33 significantly promotes EMs-related fibrosis through the activation of Wnt/β-catenin signaling. Conclusion: Our data strongly support the vital role of the IL-33/ST2 pathway in EMs-associated fibrosis and emphasize the importance of the EMT in the pathophysiology of fibrosis. Targeting the IL-33/ST2/Wnt/β-catenin axis may hold promise as a feasible therapeutic approach for controlling fibrosis in EMs.

22 June 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
YWYuning Wang
Yuning Wang
YCYun Chen
Yun Chen
YXYinping Xiao
Yinping Xiao
JRJingyao Ruan
Jingyao Ruan
QTQi Tian
Qi Tian
XYXiaofang Yi
Xiaofang Yi
Background: Endometriosis (EMs) is a chronic inflammatory condition that is highly heterogeneous. Current clinical staging fails to accurately predict drug responses and prognosis. In this study, we aimed to reveal the heterogeneity of ectopic lesions and investigate the possible underlying mechanisms using transcriptomic data and clinical information.Methods: The EMs microarray dataset GSE141549 was obtained from the Gene Expression Omnibus database. Unsupervised hierarchical clustering was performed to identify EMs subtypes, which was followed by the functional enrichment analysis and estimation of immune infiltrates. Subtype-associated gene signatures were identified and further validated in other independent datasets, including GSE25628, E-MTAB-694, and GSE23339. Additionally, tissue microarrays (TMAs) were generated from premenopausal patients with EMs to investigate the potential clinical implications of the two identified subtypes.Results: The unsupervised clustering analysis revealed that ectopic EMs lesions can be classified into two distinct subtypes: stroma-enriched (S1) and immune-enriched (S2). The functional analysis revealed that S1 correlated with fibroblast activation and extracellular matrix remodeling in the ectopic milieu, whereas S2 was characterized by the upregulation of immune pathways and a higher positive correlation with the immunotherapy response. Moreover, we identified a subtype signature composed of FHL1 and SORBS1, and constructed a subtype diagnostic model. Based on the cohort data from the TMAs, we found that S2 was strongly associated with the failure of/intolerance to hormone therapy.Conclusions: This study identified two distinct subtypes that are varyingly associated with hormone resistance, stroma-immunity, and molecular features, thereby highlighting the importance of this stromal-immune heterogeneity in identifying EMs subtypes and providing novel insights into future personalized hormone-free therapy in EMs.

30 January 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
QTQi Tian
Qi Tian
JRJingyao Ruan
Jingyao Ruan
YWYuning Wang
Yuning Wang
YXYinping Xiao
Yinping Xiao
QCQi Cheng
Qi Cheng
XYXiaofang Yi
Xiaofang Yi
As a dual-function metabolite, succinate has emerged in cell function and plays a key signaling role in linking mitochondrial function to other cellular functions. Succinate accumulation in the cytoplasm is commonly associated with hypoxia in the microenvironment and immune cell activation. Extracellular succinate released into the microenvironment is considered an inflammatory alarm that can be sensed by its membrane receptor SUCNR1, which boosts proinflammatory responses and acts akin to classical hormones and cytokines. Succinate plays an important role in the development of inflammatory diseases. Whether succinate facilitates the progression of endometriosis (EMs), characterized by chronic inflammation and peritoneal adhesion, is worth exploring. We mimicked the ectopic milieu in vitro and in vivo to evaluate the main source and potential role of succinate in endometriosis. We assessed the molecular and functional effects of succinate on macrophages and peritoneal mesothelial cells in peritoneal cavity. The effect of succinate/SUCNR1 signaling on ectopic endometrial stromal cells (ESCs) was further explored in this study. In this study, we used targeted organic acid metabolomics analysis and in vitro assays to assess the potential accumulation of succinate in the peritoneal fluid of EMs patients. We examined its correlation with disease severity, Visual Analogue Scale, and the Endometriosis Fertility Index. Flow cytometry, enzyme linked immunosorbent assay, western blot assay, quantitative real-time PCR, and other molecular biology techniques were used to explore the potential mechanisms. By mimicking the ectopic milieu, we constructed an in vitro co-culture system and found that M1 polarized macrophages and that the peritoneal mesothelial cell line (HMrSV5) mainly released succinate into their microenvironment and activated the succinate receptor (SUCNR1) signal, which further polarized the macrophages and significantly enhanced the invasive survival of ESCs, and the adhesion to the peritoneum. We further investigated the pathological effects of extracellular succinate in vivo using a xenograft mouse models of endometriosis. Succinate-SUCNR1 signaling facilitates the creation of inflammatory cells and plays a vital role in EMs progression and peritoneal adhesion. Our work on the molecular mechanisms underlying succinate accumulation and function will help elucidate the phenotypic mysteries of pain and infertility in EMs. Video Abstract

14 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
XZXiaoyu Zhou
Xiaoyu Zhou
QSQianzhi Sun
Qianzhi Sun
YZYunxi Zheng
Yunxi Zheng
TWTing Wang
Ting Wang
YCYun Chen
Yun Chen
XYXiaofang Yi
Xiaofang Yi
Objectives: The reproductive impact of bowel involvement in deep endometriosis (DE) after fertility-preserving surgery remains controversial. We aimed to determine whether bowel endometriosis (BE) is independently associated with postoperative pregnancy and live birth and to clarify its influence on conception pathways. Methods: This retrospective cohort study was conducted at a tertiary referral center between 2017 and 2024. Women aged 18–45 years who underwent laparoscopic fertility-preserving surgery for histologically confirmed DE and wished to conceive were included. Primary outcomes were postoperative pregnancy and live birth. The secondary outcome was conception mode, classified as spontaneous conception or medically assisted reproduction (MAR). Results: A total of 202 women were analyzed (127 without bowel involvement; 75 with BE). During follow-up, 140 women achieved pregnancy and 119 had a live birth. Pregnancy occurred in 64.0% of women with BE and 72.4% without bowel involvement (adjusted hazard ratio [aHR], 0.88; 95% confidence interval [CI], 0.60–1.28). Live birth occurred in 50.7% and 63.8%, respectively (aHR, 0.87; 95% CI, 0.57–1.32). BE was associated with lower cumulative incidence of spontaneous pregnancy (adjusted subdistribution hazard ratio, 0.53; 95% CI, 0.30–0.94) and higher MAR pregnancy (adjusted subdistribution hazard ratio, 1.72; 95% CI, 1.01–2.92). An inverse age–pregnancy association above 30 years in women with BE was an exploratory finding. Conclusions: BE was not significantly associated with reduced pregnancy or live birth after fertility-preserving surgery for DE. Given the limited precision of the estimates, clinically meaningful differences in pregnancy and live birth cannot be excluded. However, its association with a shift in conception pathway, characterized by fewer spontaneous conceptions and greater reliance on MAR, supports individualized fertility counselling.

7 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
QTQi Tian
Qi Tian
JRJingyao Ruan
Jingyao Ruan
YWYuning Wang
Yuning Wang
YXYinping Xiao
Yinping Xiao
QCQi Cheng
Qi Cheng
XYXiaofang Yi
Xiaofang Yi
Background As a dual-function metabolite, succinate has emerged in cell function and plays a key signaling role in linking mitochondrial function to other cellular functions. Succinate accumulation in the cytoplasm is commonly associated with hypoxia in the microenvironment and immune cell activation. Meanwhile, extracellular succinate released into the microenvironment is considered an inflammatory alarm that can be sensed by its membrane receptor SUCNR1, boosts proinflammatory responses and acts akin to classical hormones and cytokines. Succinate has been reported to play an important role in inflammatory disease. It is worth exploring whether succinate can facilitate the progress of endometriosis (EMs), which is characterized by chronic inflammation and peritoneal adhesion. Objective To evaluate the main source and potential role of succinate in endometriosis, we mimics the ectopic milieu in vitro and in vivo. The molecular and functional effects of succinate on macrophages and peritoneal mesothelial cells in peritoneal cavity were assessed. The succinate/SUCNR1 signal acting on ectopic endometrial stromal cells (ESCs) was further explored in this study. Methods In this study, we used targeted organic acid metabolomics analysis and in vitro assay to assess whether there was an obvious accumulation of succinate in the peritoneal fluid of EMs patients and its correlated with disease severity, Visual Analogue Scale (VAS), and the Endometriosis Fertility Index (EFI). Flow cytometry, Enzyme linked immunosorbent assay (ELISA), western-blot assay, and quantitative real-time PCR, and other molecular biology techniques were used for exploring the potential mechanisms. Results By mimicking the ectopic milieu, we constructed an in vitro co-culture system and found that M1 polarized macrophages and the peritoneal mesothelial cell line (HMrSV5) mainly released succinate into their microenvironment and activated the succinate receptor (SUCNR1) signal, which further polarizes macrophages and significantly enhances the invasive survival of ESCs, and the adhesion with peritoneum. We further investigated the pathological effect of extracellular succinate in vivo using xenograft mouse models of endometriosis. Conclusions Collectively, the succinate-SUCNR1 signal facilitates in creating the inflammatory nice and plays a vital role in EMs progression and peritoneal adhesion. Our work on the molecular mechanism of succinate accumulation and function will be helpful to elucidate the phenotypic mystery of pain and infertility in EMs.